Interpace to Present Data at the ATA Annual Meeting
October 29, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will be presenting new data on the performance of its molecular thyroid products at the upcoming 89th...
Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans
September 30, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
In-Network Access for Thyroid Assays for More than 5 Million Members PARSIPPANY, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it...
Interpace Diagnostics Announces Publication of Important New Data on Thyroid Test Performance
May 01, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Data from Registry Study Confirms the Value of ThyGenX® and ThyraMIR® in a Clinical Setting PARSIPPANY, NJ, May 01, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc....
Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica
April 02, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing
November 07, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...